PETV - PetVivo Holdings Inc. Stock Price, Fair Value and News

0.79USD-0.05 (-5.95%)Market Closed

Market Summary

USD0.79-0.05

Market Closed

-5.95%

PETV Alerts

1 major insider buys recently.

PETV Stock Price

View Fullscreen

PETV RSI Chart

PETV Valuation

Market Cap

14.1M

Price/Earnings (Trailing)

-1.32

Price/Sales (Trailing)

13.47

EV/EBITDA

-1.33

Price/Free Cashflow

-1.85

PETV Price/Sales (Trailing)

PETV Profitability

Operating Margin

100.00%

EBT Margin

-1016.55%

Return on Equity

-1.2K%

Return on Assets

-292.95%

Free Cashflow Yield

-53.95%

PETV Fundamentals

PETV Revenue

Revenue (TTM)

1.0M

Rev. Growth (Yr)

16.82%

Rev. Growth (Qtr)

187.36%

PETV Earnings

Earnings (TTM)

-10.6M

Earnings Growth (Yr)

24.3%

Earnings Growth (Qtr)

52.21%

Breaking Down PETV Revenue

Last 7 days

21.7%

Last 30 days

-22.2%

Last 90 days

-28.2%

Trailing 12 Months

-65.7%

How does PETV drawdown profile look like?

PETV Financial Health

Current Ratio

0.9

PETV Investor Care

Shares Dilution (1Y)

54.88%

Diluted EPS (TTM)

-0.88

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	917.2K	976.2K	960.3K	1.0M
2022	115.6K	169.6K	387.9K	847.0K
2021	12.6K	14.7K	14.9K	65.4K
2020	3.6K	5.8K	8.1K	10.3K
2018	1.5K	0	0	0
2017	7.1K	6.3K	3.7K	1.6K
2016	75.0K	58.0K	41.1K	24.1K
2015	0	133.4K	126.2K	110.9K
2012	72.1K	0	0	0
2011	74.5K	0	73.7K	72.9K
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of PetVivo Holdings Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 15, 2024	lai john	bought	90,000	0.6	150,000	ceo and president
Aug 21, 2023	martin james rudolph	bought	51,003	2.29497	22,224	-
Aug 19, 2023	jasper joseph william	sold (taxes)	16,242	1.33	12,212	-
Mar 15, 2023	costantino robert j	bought	10,132	3.02455	3,350	-
Mar 13, 2023	jasper joseph william	bought	6,200	3.1	2,000	-
Mar 01, 2023	jasper joseph william	bought	1,470	2.94	500	-
Feb 28, 2023	jasper joseph william	bought	1,563	3.12	501	-
Feb 27, 2023	jasper joseph william	bought	4,149	2.96574	1,399	-
Feb 24, 2023	lai john	acquired	-	-	60,600	ceo and president
Feb 24, 2023	jasper joseph william	bought	7,736	2.97538	2,600	-

Which funds bought or sold PETV recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 17, 2024	Fiduciary Alliance LLC	unchanged	-	-400	1,000	-%
Apr 16, 2024	Asset Dedication, LLC	unchanged	-	1,000	16,000	-%
Mar 11, 2024	VANGUARD GROUP INC	reduced	-74.32	-365,375	63,446	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	new	-	23,688	23,688	-%
Feb 15, 2024	RIVERBRIDGE PARTNERS LLC	unchanged	-	-11,208	15,231	-%
Feb 14, 2024	CVI Holdings, LLC	reduced	-0.13	-28,353	20,843	0.04%
Feb 14, 2024	Mariner, LLC	new	-	19,345	19,345	-%
Feb 14, 2024	BOOTHBAY FUND MANAGEMENT, LLC	new	-	20,140	20,140	-%
Feb 14, 2024	Regal Investment Advisors LLC	unchanged	-	-1,854	2,520	-%
Feb 14, 2024	CLEAR STREET LLC	unchanged	-	-2,000	2,000	-%

Are Funds Buying or Selling PETV?

Are funds buying PETV calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PETV

No. of Funds

PETV Alerts

1 major insider buys recently.

Unveiling PetVivo Holdings Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 18, 2024	a.l. sarroff fund, llc	11.75%	1,970,133	SC 13G/A
Jan 22, 2024	cruden stanley c	9.17%	1,331,090	SC 13D
Jan 18, 2024	a.l. sarroff fund, llc	12.22%	1,695,022	SC 13G/A
Aug 22, 2023	cruden stanley c	8.40%	1,102,740	SC 13D
Aug 21, 2023	a.l. sarroff fund, llc	12.07%	1,583,911	SC 13G
Apr 18, 2023	cruden stanley c	8.10%	909,280	SC 13G
Mar 17, 2023	cruden stanley c	8.39%	909,280	SC 13D
Feb 24, 2023	cruden stanley c	8.24%	9e+05	SC 13G
Jan 18, 2023	cruden stanley c	8.22%	882,237	SC 13G
Nov 15, 2022	cruden stanley c	7.78%	793,031	SC 13G

Recent SEC filings of PetVivo Holdings Inc.

View All Filings

Date Filed	Form Type	Document
Apr 22, 2024	8-K	Current Report
Apr 19, 2024	8-K	Current Report
Apr 17, 2024	4	Insider Trading
Apr 16, 2024	8-K	Current Report
Apr 09, 2024	8-K	Current Report
Apr 03, 2024	4	Insider Trading
Mar 20, 2024	3	Insider Trading
Mar 18, 2024	SC 13G/A	Major Ownership Report
Mar 14, 2024	8-K	Current Report
Mar 11, 2024	8-K	Current Report

Peers (Alternatives to PetVivo Holdings Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	185.5B	40.1B	-2.69%	-2.54%	32.41	4.63	-8.12%	-17.45%
BDX	67.5B	19.5B	-4.86%	-10.59%	53.77	3.46	4.02%	-22.04%
ALGN	23.6B	3.9B	-2.36%	-14.10%	52.95	6.1	3.42%	23.09%
BAX	20.8B	14.8B	-2.22%	-9.67%	7.83	1.4	2.12%	209.17%
MID-CAP
HSIC	9.4B	12.3B	-0.49%	-14.47%	22.62	0.76	-2.44%	-22.68%
ATR	9.3B	3.5B	-1.02%	16.40%	32.52	2.65	4.97%	18.89%
BIO	8.1B	2.7B	-18.63%	-38.25%	-12.74	3.04	-4.68%	82.43%
XRAY	6.4B	4.0B	-5.77%	-25.53%	-47.67	1.62	1.10%	85.84%
AXNX	3.4B	366.4M	-2.62%	10.65%	-558.61	9.25	33.86%	89.83%
PDCO	2.3B	6.6B	-4.73%	-4.84%	12.02	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-11.22%	-19.13%	-1.92	0.41	7.73%	-1066.14%
ANIK	384.6M	166.7M	1.30%	-3.37%	-4.65	2.31	6.67%	-456.34%
ANGO	235.1M	324.0M	12.50%	-31.24%	-1.22	0.73	-3.19%	-337.41%
APYX	45.7M	52.3M	5.60%	-56.15%	-2.44	0.87	17.61%	19.28%
AEMD	4.0M	3.7M	-11.70%	184.91%	-0.32	1.06	5.77%	8.23%

PetVivo Holdings Inc. News

Latest updates

PetVivo Holdings Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2018Q1	2017Q4	2017Q3	2017Q2	2017Q1
Revenue	187.4%	595,891	207,366	117,183	125,599	510,109	223,280	58,174	55,460	51,004	4,977	4,145	5,275	506	4,790	2,006	1,003	-	-	327	1,183	45.00
Gross Profit	521.2%	412,804	66,453	34,914	23,648	286,422	75,121	5,154	-41,646	-47,993	4,977	-906	-5,070	507	4,440	2,006	-10,632	-	-	327	1,183	-
Operating Expenses	-15.4%	2,546,428	3,010,796	2,928,491	2,352,621	2,605,240	2,194,689	1,971,247	1,735,356	1,609,658	1,108,333	517,613	307,893	385,897	823,007	444,074	509,405	956,001	-	-	-	-
S&GA Expenses	-4.3%	1,032,575	1,078,725	941,886	838,174	1,047,549	867,985	656,569	657,625	404,462	235,767	49,731	-11,768	24,484	35,580	46,682	86,437	899,879	-	-	-	-
R&D Expenses	-3.8%	231,066	240,281	223,807	230,380	248,157	140,384	71,656	187,238	34,326	116,380	136,937	67,965	30,265	-	-	772	56,122	16,659	22,293	23,866	50,656
EBITDA Margin	12.8%	-10.05	-11.52	-9.74	-9.36	-9.49	-19.01	-37.71	-42.74	-56.06	-209	-219	-278	-327	-336	-	-	-	-	-	-	-
Interest Expenses	14.2%	-2,098	-2,444	-	-	7,200	7,979	665	239	15,522	-2,118	-3,790	-171,799	-48,666	140,651	13,962	8,330	2,282	45,675	-	-	-
Earnings Before Taxes	52.2%	-1,749,848	-3,661,153	-2,893,577	-2,328,973	-2,311,618	-2,111,589	-1,965,428	-1,776,763	-1,642,129	-1,105,474	-490,629	-323,017	-1,037,753	-1,348,002	-814,008	-511,481	-958,283	-	-	-	-
EBT Margin	12.8%	-10.17	-11.66	-9.88	-9.50	-9.64	-19.32	-38.26	-43.39	-54.45	-198	-217	-280	-359	-398	-	-	-	-	-	-	-
Net Income	52.2%	-1,749,848	-3,661,153	-2,893,577	-2,328,973	-2,311,618	-2,111,589	-1,965,428	-1,776,763	-1,642,129	-1,105,474	-490,629	-323,017	-1,037,753	-1,348,002	-814,008	-511,481	-958,283	-	-	-	-
Net Income Margin	12.8%	-10.17	-11.66	-9.88	-9.50	-9.64	-19.32	-38.26	-43.39	-54.45	-198	-217	-280	-359	-398	-	-	-	-	-	-	-
Free Cashflow	40.6%	-1,476,706	-2,487,817	-2,210,763	-1,424,319	-1,960,951	-2,106,551	-1,726,596	-1,711,762	-1,260,029	-1,106,537	-278,122	-12,582	-341,088	-277,614	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-10.6%	3,630	4,062	3,099	2,439	2,568	4,051	5,724	7,427	8,496	9,914	945	835	899	726	579	523	660	648	738	691	1,185
Current Assets	-25.9%	1,493	2,016	1,016	1,424	1,736	3,383	5,069	6,755	8,035	9,511	246	147	386	302	268	197	324	178	128	56.00	297
Cash Equivalents	44.9%	80.00	55.00	219	475	375	2,337	4,379	6,107	7,554	8,817	143	24.00	231	166	129	11.00	106	20.00	66.00	6.00	187
Inventory	7.7%	467	434	406	370	375	305	181	98.00	105	75.00	-	-	10.00	-	-	-	12.00	12.00	12.00	12.00	48.00
Net PPE	23.7%	823	665	649	631	520	341	311	312	269	207	202	214	204	178	145	110	24.00	27.00	30.00	37.00	36.00
Liabilities	-11.0%	2,735	3,073	2,701	1,714	1,784	1,487	1,471	1,441	1,246	1,366	1,661	1,732	1,561	2,654	2,154	1,559	1,408	1,447	1,893	1,536	-
Current Liabilities	-13.2%	1,662	1,915	1,465	1,454	1,565	1,254	1,221	1,173	1,106	1,218	1,341	1,405	1,208	2,272	2,014	1,148	1,040	1,097	1,537	1,536	1,498
Short Term Borrowings	-	-	-	-	-	-	-	-	-	4.00	6.00	7.00	39.00	33.00	23.00	16.00	-	-	-	-	-	-
Shareholder's Equity	-9.5%	895	989	398	725	784	2,563	4,253	5,987	7,250	8,548	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-2.2%	-80,148	-78,398	-74,737	-71,844	-69,515	-67,203	-65,091	-63,126	-61,349	-59,707	-58,602	-58,111	-57,788	-56,750	-55,402	-54,588	-54,077	-53,525	-53,006	-52,505	-51,208
Additional Paid-In Capital	2.1%	81,056	79,374	75,124	72,421	70,289	69,757	69,334	69,103	68,590	68,246	57,879	57,208	57,120	54,798	53,804	53,495	53,167	52,601	51,710	51,553	50,538
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	136	126	118	112	125	122	118	112	110
Shares Outstanding	7.8%	14,921	13,842	11,830	10,950	10,047	10,021	9,988	9,988	9,757	8,749	6,946	6,799	6,006	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	14,379	-	-	-	16,361	-	-	-	36,170	-	-	-	7,210	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	47.1%	-1,290	-2,441	-2,163	-1,294	-1,750	-2,047	-1,701	-1,649	-1,185	-1,084	-255	10.00	-304	-236	-235	-82.95	-127	-114	-173	-139	-160
Share Based Compensation	-14.8%	517	607	413	393	532	306	231	270	273	104	56.00	-436	52.00	654	183	72.00	465	135	191	765	279
Cashflow From Investing	-302.8%	-186	-46.22	-47.39	-130	-210	-58.67	-24.90	-72.12	-74.85	-30.15	-6.06	-2.40	-49.77	-62.10	-45.89	-16.82	-20.39	-5.23	-21.26	-12.58	-9.04
Cashflow From Financing	-35.4%	1,502	2,324	1,954	1,525	-1.61	65.00	-1.56	275	-3.70	9,789	381	-214	420	336	399	4.00	234	74.00	254	-28.29	313

PETV Income Statement

2023-12-31

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues	$ 595,891	$ 510,109	$ 920,440	$ 791,563
Cost of Sales	183,087	223,687	406,270	424,866
Gross Profit	412,804	286,422	514,170	366,697
Operating Expenses:
Sales and Marketing	1,032,575	1,047,549	3,053,184	2,572,103
Research and Development	231,066	248,157	695,156	460,197
General and Administrative	1,282,787	1,309,534	4,737,374	3,738,876
Total Operating Expenses	2,546,428	2,605,240	8,485,714	6,771,176
Operating Loss	(2,133,624)	(2,318,818)	(7,971,544)	(6,404,479)
Other (Expense) Income
Loss on Extinguishment of Debt			(534,366)
Settlement Expense			(180,000)
Extinguishment of payables	385,874		385,874
Interest (Expense) Income	(2,098)	7,200	(4,542)	15,844
Total Other Income (Expense)	383,776	7,200	(333,034)	15,844
Loss before taxes	(1,749,848)	(2,311,618)	(8,304,578)	(6,388,635)
Income Tax Provision
Net Loss	$ (1,749,848)	$ (2,311,618)	$ (8,304,578)	$ (6,388,635)
Net Loss Per Share:
Earnings per share, basic	$ (0.12)	$ (0.23)	$ (0.64)	$ (0.64)
Earnings per share, diluted	$ (0.12)	$ (0.23)	$ (0.64)	$ (0.64)
Weighted Average Common Shares Outstanding:
Weighted average number of shares outstanding, basic	14,271,530	10,098,658	12,976,851	10,047,040
Weighted average number of shares outstanding, diluted	14,271,530	10,098,658	12,976,851	10,047,040

PETV Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Mar. 31, 2023
Current Assets
Cash and cash equivalents	$ 80,085	$ 475,314
Accounts receivable	518,686	86,689
Inventory	467,467	370,283
Prepaid expenses and other assets	426,646	491,694
Total Current Assets	1,492,884	1,423,980
Property and Equipment, net	823,280	630,852
Other Assets:
Operating lease right-of-use asset	1,253,815	317,981
Patents and trademarks, net	32,333	38,649
Security deposit	27,490	27,490
Total Other Assets	1,313,638	384,120
Total Assets	3,629,802	2,438,952
Current Liabilities
Accounts payable	1,094,152	588,713
Accrued expenses	241,959	779,882
Operating lease liability – short term	196,263	78,149
Notes payables and accrued interest	129,746	6,936
Total Current Liabilities	1,662,120	1,453,680
Non-Current Liabilities
Note payable and accrued interest (net of current portion)	15,030	20,415
Operating lease liability (net of current portion)	1,057,552	239,832
Total Non-Current Liabilities	1,072,582	260,247
Total Liabilities	2,734,702	1,713,927
Commitments and Contingencies (see Note 9)
Stockholders’ Equity:
Preferred Stock, par value $0.001, 20,000,000 shares authorized, no shares issued and outstanding at December 31, 2023 and March 31, 2023
Common Stock, par value $0.001, 250,000,000 shares authorized, 14,921,209 and 10,950,220 issued and outstanding at December 31, 2023 and March 31, 2023, respectively	14,921	10,950
Common Stock to be Issued		137,500
Common Stock Receivable	(27,000)
Additional Paid-In Capital	81,055,786	72,420,604
Accumulated Deficit	(80,148,607)	(71,844,029)
Total Stockholders’ Equity	895,100	725,025
Total Liabilities and Stockholders’ Equity	$ 3,629,802	$ 2,438,952

About PetVivo Holdings Inc.

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

CEO	Mr. John Lai
WEBSITE	petvivo.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	25

PetVivo Holdings Inc. Frequently Asked Questions

What is the ticker symbol for PetVivo Holdings Inc.? What does PETV stand for in stocks?

PETV is the stock ticker symbol of PetVivo Holdings Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of PetVivo Holdings Inc. (PETV)?

As of Tue Apr 23 2024, market cap of PetVivo Holdings Inc. is 14.09 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PETV stock?

You can check PETV's fair value in chart for subscribers.

What is the fair value of PETV stock?

You can check PETV's fair value in chart for subscribers. The fair value of PetVivo Holdings Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of PetVivo Holdings Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PETV so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is PetVivo Holdings Inc. a good stock to buy?

The fair value guage provides a quick view whether PETV is over valued or under valued. Whether PetVivo Holdings Inc. is cheap or expensive depends on the assumptions which impact PetVivo Holdings Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PETV.

What is PetVivo Holdings Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, PETV's PE ratio (Price to Earnings) is -1.32 and Price to Sales (PS) ratio is 13.47. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PETV PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on PetVivo Holdings Inc.'s stock?

In the past 10 years, PetVivo Holdings Inc. has provided 0.735 (multiply by 100 for percentage) rate of return.